585 related articles for article (PubMed ID: 16469181)
1. Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide.
Glaser ST; Deutsch DG; Studholme KM; Zimov S; Yazulla S
Vis Neurosci; 2005; 22(6):693-705. PubMed ID: 16469181
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate.
Vandevoorde S; Fowler CJ
Br J Pharmacol; 2005 Aug; 145(7):885-93. PubMed ID: 15895107
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats.
Nucci C; Gasperi V; Tartaglione R; Cerulli A; Terrinoni A; Bari M; De Simone C; Agrò AF; Morrone LA; Corasaniti MT; Bagetta G; Maccarrone M
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2997-3004. PubMed ID: 17591864
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis--a difficult issue to handle.
Fowler CJ; Tiger G; Ligresti A; López-Rodríguez ML; Di Marzo V
Eur J Pharmacol; 2004 May; 492(1):1-11. PubMed ID: 15145699
[TBL] [Abstract][Full Text] [Related]
5. RNA interference-mediated knockdown of dynamin 2 reduces endocannabinoid uptake into neuronal dCAD cells.
McFarland MJ; Bardell TK; Yates ML; Placzek EA; Barker EL
Mol Pharmacol; 2008 Jul; 74(1):101-8. PubMed ID: 18436710
[TBL] [Abstract][Full Text] [Related]
6. Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172.
Fegley D; Kathuria S; Mercier R; Li C; Goutopoulos A; Makriyannis A; Piomelli D
Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8756-61. PubMed ID: 15138300
[TBL] [Abstract][Full Text] [Related]
7. Studies of anandamide accumulation inhibitors in cerebellar granule neurons: comparison to inhibition of fatty acid amide hydrolase.
Hillard CJ; Shi L; Tuniki VR; Falck JR; Campbell WB
J Mol Neurosci; 2007 Sep; 33(1):18-24. PubMed ID: 17901541
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors.
Dickason-Chesterfield AK; Kidd SR; Moore SA; Schaus JM; Liu B; Nomikos GG; Felder CC
Cell Mol Neurobiol; 2006; 26(4-6):407-23. PubMed ID: 16736384
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo imaging of fatty acid amide hydrolase activity and its inhibition in the mouse brain.
Glaser ST; Gatley SJ; Gifford AN
J Pharmacol Exp Ther; 2006 Mar; 316(3):1088-97. PubMed ID: 16278311
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin.
Holt S; Paylor B; Boldrup L; Alajakku K; Vandevoorde S; Sundström A; Cocco MT; Onnis V; Fowler CJ
Eur J Pharmacol; 2007 Jun; 565(1-3):26-36. PubMed ID: 17397826
[TBL] [Abstract][Full Text] [Related]
11. Comparison of anandamide transport in FAAH wild-type and knockout neurons: evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake.
Ortega-Gutiérrez S; Hawkins EG; Viso A; López-Rodríguez ML; Cravatt BF
Biochemistry; 2004 Jun; 43(25):8184-90. PubMed ID: 15209515
[TBL] [Abstract][Full Text] [Related]
12. Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide.
Jonsson KO; Vandevoorde S; Lambert DM; Tiger G; Fowler CJ
Br J Pharmacol; 2001 Aug; 133(8):1263-75. PubMed ID: 11498512
[TBL] [Abstract][Full Text] [Related]
13. Identification of intracellular carriers for the endocannabinoid anandamide.
Kaczocha M; Glaser ST; Deutsch DG
Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6375-80. PubMed ID: 19307565
[TBL] [Abstract][Full Text] [Related]
14. Expression and localization of the cannabinoid receptor type 1 and the enzyme fatty acid amide hydrolase in the retina of vervet monkeys.
Bouskila J; Burke MW; Zabouri N; Casanova C; Ptito M; Bouchard JF
Neuroscience; 2012 Jan; 202():117-30. PubMed ID: 22142900
[TBL] [Abstract][Full Text] [Related]
15. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.
Di Marzo V; Melck D; Orlando P; Bisogno T; Zagoory O; Bifulco M; Vogel Z; De Petrocellis L
Biochem J; 2001 Aug; 358(Pt 1):249-55. PubMed ID: 11485574
[TBL] [Abstract][Full Text] [Related]
16. Vanilloid receptor 1 (TRPV1/VR1) co-localizes with fatty acid amide hydrolase (FAAH) in retinal amacrine cells.
Zimov S; Yazulla S
Vis Neurosci; 2007; 24(4):581-91. PubMed ID: 17686199
[TBL] [Abstract][Full Text] [Related]
17. The endocannabinoid system in the brain of Carassius auratus and its possible role in the control of food intake.
Valenti M; Cottone E; Martinez R; De Pedro N; Rubio M; Viveros MP; Franzoni MF; Delgado MJ; Di Marzo V
J Neurochem; 2005 Nov; 95(3):662-72. PubMed ID: 16135090
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the endocannabinoid system in human spermatozoa and involvement of transient receptor potential vanilloid 1 receptor in their fertilizing ability.
Francavilla F; Battista N; Barbonetti A; Vassallo MR; Rapino C; Antonangelo C; Pasquariello N; Catanzaro G; Barboni B; Maccarrone M
Endocrinology; 2009 Oct; 150(10):4692-700. PubMed ID: 19608651
[TBL] [Abstract][Full Text] [Related]
19. Further evidence for the existence of a specific process for the membrane transport of anandamide.
Ligresti A; Morera E; Van Der Stelt M; Monory K; Lutz B; Ortar G; Di Marzo V
Biochem J; 2004 May; 380(Pt 1):265-72. PubMed ID: 14969584
[TBL] [Abstract][Full Text] [Related]
20. Endocannabinoid metabolism in the absence of fatty acid amide hydrolase (FAAH): discovery of phosphorylcholine derivatives of N-acyl ethanolamines.
Mulder AM; Cravatt BF
Biochemistry; 2006 Sep; 45(38):11267-77. PubMed ID: 16981687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]